UPDATE: Credit Suisse Initiates Baxter International at Outperform on Solid Top-Line Growth
In a report published Wednesday, Credit Suisse analyst Bruce Nudell initiated coverage on Baxter International (NYSE: BAX) with an Outperform rating and $81.00 price target.
In the report, Credit Suisse noted, “We see BAX's solid top-line growth (4.6% organic growth in 2012-15, 1% ahead of large-cap med-tech peers) and dividend prospects (2.8% yield, ~1% above peers), combined with in line valuation (on a P/E and PEG basis), as supportive of an Outperform rating. Our $81 DCF-derived target price (17.5 and 15.7 times our 2013-14 EPS estimates) assumes an 8.5% WACC and 1.5% terminal growth rate.”
Baxter International closed on Tuesday at $71.45.
Latest Ratings for BAX
|Oct 2014||Credit Suisse||Maintains||Outperform|
|Oct 2014||Morgan Stanley||Maintains||Equal-weight|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.